Avacopan

Records for this ingredient, by country (identity only).

ATC L04AJ05 · 10 markets · 12 records

Avacopan 10 markets · 12 records Forms
Filters

AU 3 records · 1 shown of 1 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 10 mgcapsuleTAVNEOSTAVNEOS avacopan 10 mg hard capsule bottle also in US·GB·CA
    +4Other 4 marketsSGCNJPFR
    unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

  • 10 mgcapsuleTAVNEOS HARD CAPSULE 10MG also in AU·US·GB
    +4Other 4 marketsCACNJPFR

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

JP 1 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 10 mgcapsuleタブネオスカプセル10mg also in AU·US·GB
    +4Other 4 marketsCASGCNFR

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

  • 10 mgcapsuleTAVNEOS 10 mg, gélule also in AU·US·GB
    +4Other 4 marketsCASGCNJP

Side-by-side table

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.